Adeona (AEN) Reports Encouraging Data from Zinc Therapy Phase I/II in ALS
Go back to Adeona (AEN) Reports Encouraging Data from Zinc Therapy Phase I/II in ALS| Adeona Pharmaceuticals, Inc. (NYSE: AEN) | Delayed: 2.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $2.53 | |||
| Open | $2.53 | 52 Week Low | $2.53 | |||
| Day High | $2.53 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $-0.23 | |||
| Volume | 1,099 | |||||
